Cargando…

Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations

This study investigated the associations between image features extracted from tumor (18)F-fluorodeoxyglucose (FDG) uptake and genetic alterations in patients with lung cancer. A total of 137 patients (age, 62.7 ± 10.2 years) who underwent FDG positron emission tomography/computed tomography (PET/CT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Gahyun, Kim, Jinho, Cha, Hongui, Park, Woong-Yang, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Park, Yong-Jin, Choi, Joon Young, Lee, Kyung-Han, Lee, Se-Hoon, Moon, Seung Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411040/ https://www.ncbi.nlm.nih.gov/pubmed/32764738 http://dx.doi.org/10.1038/s41598-020-70168-x

Ejemplares similares

Comparative analysis of batch correction methods for FDG PET/CT using metabolic radiogenomic data of lung cancer patients
por: Lee, Hyunjong, et al.
Publicado: (2023)

Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma
por: Park, Sehhoon, et al.
Publicado: (2022)

Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer
por: Lee, Jiyun, et al.
Publicado: (2019)

Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity
por: Hong, Tae Hee, et al.
Publicado: (2020)

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
por: Kim, Youjin, et al.
Publicado: (2019)

Metabolic parameters on baseline (18)F-FDG PET/CT are potential predictive biomarkers for immunotherapy in patients with head and neck squamous cell carcinoma
por: Kwon, Hye Ryeong, et al.
Publicado: (2022)

Predictive and Prognostic Value of (18)F-fluorodeoxyglucose Uptake Combined with Thymidylate Synthase Expression in Patients with Advanced Non-Small Cell Lung Cancer
por: Moon, Seung Hwan, et al.
Publicado: (2019)

The prognostic value of radiomic features from pre- and post-treatment (18)F-FDG PET imaging in patients with nasopharyngeal carcinoma
por: Kim, Soo Jeong, et al.
Publicado: (2023)

Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer?
por: Lee, Jiyun, et al.
Publicado: (2020)

Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases
por: Ahn, Soomin, et al.
Publicado: (2016)

Relationship of the standard uptake value of (18)F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm
por: Park, Soeun, et al.
Publicado: (2021)

Predicting the Efficacy of SBRT for Lung Cancer with (18)F-FDG PET/CT Radiogenomics
por: Chen, Kuifei, et al.
Publicado: (2023)

Long-term Survival in Non–Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment
por: Kim, Hongsik, et al.
Publicado: (2022)

Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors
por: Kim, Hongsik, et al.
Publicado: (2021)

Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model
por: Ku, Bo Mi, et al.
Publicado: (2018)

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?
por: Jung, Hyun Ae, et al.
Publicado: (2020)

Primary Benign Intraosseous Meningioma on (18)F-FDG PET/CT Mimicking Malignancy
por: Kim, Ho Seong, et al.
Publicado: (2014)

Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma
por: Kong, Doo-Sik, et al.
Publicado: (2016)

Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer
por: Lee, Hwanhee, et al.
Publicado: (2023)

(18)F-FDG PET Metabolic Parameters and MRI Perfusion and Diffusion Parameters in Hepatocellular Carcinoma: A Preliminary Study
por: Ahn, Sung Jun, et al.
Publicado: (2013)

Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis
por: Park, Yong-Jin, et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea
por: Lee, Kangkook, et al.
Publicado: (2020)

Expanded Access Program Pralsetinib in Advanced Non–Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement
por: Jeon, Youngkyung, et al.
Publicado: (2023)

Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation
por: Park, Yong-Jin, et al.
Publicado: (2021)

Detection of distant metastasis to skeletal muscle by (18)F-FDG-PET in a case of intrahepatic cholangiocarcinoma
por: Park, Se Kyung, et al.
Publicado: (2010)

Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis
por: Byeon, Seonggyu, et al.
Publicado: (2016)

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2022)

EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation
por: Park, Sehhoon, et al.
Publicado: (2020)

Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2021)

Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using (18)F-FDG PET/CT, EZRIN, and KI67
por: Kim, Byung-Chul, et al.
Publicado: (2021)

(18)F-FDG uptake of visceral adipose tissue on preoperative PET/CT as a predictive marker for breast cancer recurrence
por: Kim, Hyun Jeong, et al.
Publicado: (2022)

The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer
por: Jung, Hyun Ae, et al.
Publicado: (2020)

Prognostic value of volumetric metabolic parameters measured by [(18)F]Fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer
por: Park, Soo Bin, et al.
Publicado: (2014)

Splenic uptake on FDG PET/CT correlates with Kikuchi-Fujimoto disease severity
por: Seong, Hye, et al.
Publicado: (2021)

Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Patients With Nasopharyngeal Carcinoma Treated With Concurrent Chemoradiotherapy
por: Moon, Seung Hwan, et al.
Publicado: (2015)

Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer
por: Park, Sehhoon, et al.
Publicado: (2022)

Real-time autOmatically updated data warehOuse in healThcare (ROOT): an innovative and automated data collection system
por: Jung, Hyun Ae, et al.
Publicado: (2021)

Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination
por: You, Hye Jin, et al.
Publicado: (2016)

Comparison of CT and (18)F-FDG PET for Detecting Peritoneal Metastasis on the Preoperative Evaluation for Gastric Carcinoma
por: Lim, Joon Seok, et al.
Publicado: (2006)

Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ff3djnjngtq52kjol7bv2kmeu4